| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| halothane | Solution | 250 mL | |
| ketamine | Injection | 50 mg (as hydrochloride)/mL in 10-mL vial | |
| nitrous oxide | Inhalation | N/A | |
| oxygen | Inhalation (medicine gas) | N/A | |
| propofol | Aqueous emulsion | 200 mg/ 20 ml | |
| thiopental | Powder for injection | 0.5 g (as sodium) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| bupivacaine | Solution for injection | 5 mg/ml | |
| bupivacaine + glucose | Injection | 0.5%/ 80 mg/ml | |
| ephedrine | Injection | 50 mg/ml | |
| lidocaine | Injection | 2% (hydrochloride) in 2 mL ampoule | |
| lidocaine | Ointment | 5% (hydrochloride) | |
| lidocaine + epinephrine (adrenaline) | Dental cartridge | 2% (hydrochloride) + epinephrine 1:80 000 | |
| lidocaine + epinephrine (adrenaline) | Injection | 2% / 1:100 000 |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| atropine | Injection | 250 mcg/mL | |
| diazepam | Injection | 10 mg in 2-mL ampoule | |
| fentanyl | Injection | 50 mcg (citrate)/mL | |
| midazolam | Injection | 15 mg/3 ml | |
| morphine | Injection | 10 mg/ml | |
| promethazine | Injection | 25mg (hydrochloride)/ml | |
| promethazine | Oral solution | 1mg/mL | |
| promethazine | Tablet | 25 mg | |
| sufentanil | Injection | 50 mcg/mL (5 mL) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| diclofenac | Injection | 25 mg (sodium)/mL | |
| diclofenac | Suppository | 100 mg (as sodium) | |
| ibuprofen | Tablet | 200 mg | |
| ibuprofen | Tablet | 400 mg | |
| methylsalicylate | Ointment | 10% | |
| naproxen | Tablet | 250 mg | |
| paracetamol | Oral liquid | 120 mg/5 mL | |
| paracetamol | Suppository | 1 g | |
| paracetamol | Suppository | 120 mg | |
| paracetamol | Suppository | 240 mg | |
| paracetamol | Suppository | 500 mg | |
| paracetamol | Tablet | 500 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| codeine | Tablet | 30 mg | |
| fentanyl | Patch | 100 mcg/hr | |
| fentanyl | Patch | 12 mcg/hr | |
| fentanyl | Patch | 25 mcg/hr | |
| morphine | Oral liquid | 2 mg/mL (hydrochloride) | |
| morphine | Solid oral dosage form | 10 mg | |
| morphine | Tablet (controlled release) | 10 mg | |
| morphine | Tablet (controlled release) | 30 mg | |
| morphine | Tablet (controlled release) | 60 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| allopurinol | Tablet | 100 mg | |
| allopurinol | Tablet | 300 mg | |
| colchicine | Tablet | 0.5mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| azathioprine | Tablet | 50 mg | |
| ciclosporin | Capsule | 25 mg | |
| ciclosporin | Capsule | 50 mg | |
| hydroxychloroquine | Tablet | 200 mg | |
| methotrexate | Tablet | 2.5 mg | |
| penicillamine | Capsule | 250 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| cetirizine | Tablet | 10 mg | |
| chlorphenamine | Injection | 10 mg (hydrogen maleate) in 1-ml ampoule | |
| chlorphenamine | Oral liquid | 2 mg/5 ml (hydrogen maleate) | |
| chlorphenamine | Tablet | 4 mg (hydrogen maleate) | |
| cinnarizine | Tablet | 25 mg | |
| dexamethasone | Injection | 4 mg (phosphate)/mL | |
| dexamethasone | Tablet | 0.5 mg | |
| dexamethasone | Tablet | 1 mg | |
| epinephrine (adrenaline) | Injection | 1 mg in 1-mL ampoule | |
| hydrocortisone | Powder for injection | 100 mg (as sodium succinate) in vial | |
| prednisolone | Tablet | 30 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| atropine | Injection | 1 mg (sulfate) in 1-ml ampoule | |
| calcium gluconate | Injection | 100 mg/mL in 10-mL ampoule | |
| deferoxamine | Powder for injection | 500 mg | |
| methylthioninium chloride (methylene blue) | Injection | 10 mg/ml in 10-ml ampoule | |
| naloxone | Injection | 400 mcg (hydrochloride) in 1-mL ampoule | |
| penicillamine | Capsule | 250 mg | |
| potassium ferric hexacyano-ferrate(II) - 2H20 (Prussian blue) | Powder for oral administration | N/A | |
| pralidoxime | Injection | 200 mg/mL (mesilate) | |
| sodium calcium edetate | Injection | 200 mg/ml in 5-ml ampoule | |
| sodium nitrite | Injection | 30 mg/mL in 10-mL ampoule | |
| sodium thiosulfate | Injection | 250 mg/mL in 50-mL ampoule |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| carbamazepine | Tablet (chewable) | 100 mg | |
| carbamazepine | Tablet (chewable) | 200 mg | |
| clonazepam | Tablet | 2mg | |
| diazepam | Injection | 10 mg in 2-mL ampoule | |
| magnesium sulfate | Injection | 200 mg/mL in 10-mL ampoule | |
| phenobarbital | Tablet | 100 mg | |
| phenobarbitone | Injection | 100 mg/mL | |
| phenytoin | Injection | 50 mg/mL in 5-mL vial (sodium salt) | |
| phenytoin | Solid oral dosage form | 100 mg (sodium salt) | |
| valproic acid (sodium valproate) | Oral liquid | 60 mg/mL | |
| valproic acid (sodium valproate) | Tablet (controlled release) | 300 mg (enteric coated) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| albendazole | Tablet (chewable) | 400 mg | |
| ivermectin | Tablet | 3 mg | |
| mebendazole | Tablet | 100 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| praziquantel | Tablet | 600 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amoxicillin | Suspension | 125 mg/ 5 ml | |
| amoxicillin | Suspension | 250 mg/5ml | |
| amoxicillin | Tablet | 500 mg | |
| amoxicillin | Tablet | 500 mg | |
| amoxicillin + clavulanic acid | Powder for injection | 1g + 0.2g | |
| amoxicillin + clavulanic acid | Powder for injection | 500mg/ 50 mg | |
| ampicillin | Powder for injection | 1 g | |
| ampicillin | Powder for injection | 500 mg | |
| benzathine benzylpenicillin | Injection | 2 400 000 IU | |
| benzathine benzylpenicillin | Powder for injection | 1 200 000 UI | |
| benzylpenicillin | Powder for injection | 1 million IU | |
| flucloxacillin | Oral liquid | 125 mg/5 mL (sodium salt) | |
| flucloxacillin | Oral liquid | 250mg/5ml (sodium salt) | |
| flucloxacillin | Powder for injection | 500 mg | |
| flucloxacillin | Tablet | 500 mg | |
| phenoxymethylpenicillin | Tablet | 250 mg (as potassium salt) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amikacin | Injection | 250 mg/mL in 2-mL vial | |
| azithromycin | Tablet | 250 mg | |
| cefazolin | Injection | 1g | |
| cefotaxime | Powder for injection | 250 mg | |
| ceftriaxone | Powder for injection | 1 g (as sodium salt) in vial | |
| ceftriaxone | Powder for injection | 2 g (as sodium) in vial | |
| ceftriaxone | Powder for injection | 250 mg (as sodium salt) in vial | |
| ceftriaxone | Powder for injection | 500 mg | |
| ciprofloxacin | Tablet | 250 mg | |
| ciprofloxacin | Tablet | 500 mg | |
| co-trimoxazole | Injection | 96 mg/ml x 5 ml IV | |
| co-trimoxazole | Suspension | 240 mg/5 ml | |
| co-trimoxazole | Tablet | 480 mg | |
| doxycycline | Tablet | 100mg | |
| erythromycin | Oral suspension | 125 mg/5 mL (ethylsuccinate) | |
| erythromycin | Powder for injection | 1 g (lactiobonate) | |
| erythromycin | Tablet | 250 mg | |
| gentamicin | Injection | 10 mg (sulfate)/mL in 2-mL vial | |
| gentamicin | Injection | 40 mg (sulfate)/ml in 2-mL vial | |
| meropenem | Powder for injection | 500mg | |
| metronidazole | Injection | 500 mg in 100-mL vial | |
| metronidazole | Suspension | 200 mg/ 5 ml | |
| neomycin | Solid oral dosage form | 250 mg (sulfate) | |
| nitrofurantoin | Tablet | 100 mg | |
| nitrofurantoin | Tablet | 50mg | |
| spectinomycin | Powder for injection | 2 g (as hydrochloride) in vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| clofazimine | Solid oral dosage form | 100 mg | |
| clofazimine | Solid oral dosage form | 50 mg | |
| dapsone | Tablet | 100 mg | |
| dapsone | Tablet | 50 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| ethambutol | Tablet | 400mg | |
| ethambutol + isoniazid + pyrazinamide + rifampicin | Tablet | 275 mg + 75 mg + 400 mg + 150 mg | |
| ethambutol + isoniazid + rifampicin | Tablet | 275 mg + 75 mg + 150 mg | |
| isoniazid | Tablet | 100mg | |
| isoniazid | Tablet | 300mg | |
| isoniazid + rifampicin | Tablet | 150 mg + 300 mg | |
| isoniazid + rifampicin | Tablet | 75 mg + 150 mg | |
| pyrazinamide | Tablet | 500 mg | |
| rifampicin | Oral liquid | 20 mg/ml | |
| rifampicin | Solid oral dosage form | 150 mg | |
| rifampicin | Solid oral dosage form | 300 mg | |
| streptomycin | Powder for injection | 1 g |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amphotericin B | Powder for injection | 50 mg in vial | |
| fluconazole | Tablet | 200 mg | |
| flucytosine | Capsule | 250 mg | |
| griseofulvin | Tablet | 125 mg | |
| griseofulvin | Tablet | 500mg | |
| ketoconazole | Tablet | 200 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| metronidazole | Tablet | 500 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| pentamidine | Powder for injection | 300 mg (isetionate) in ampoule |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| artemether + lumefantrine | Tablet | 20 mg + 120 mg | |
| artesunate | Injection | ampoules, containing 60 mg anhydrous artesunic acid with a separate ampoule of 5% sodium bicarbonate solution | |
| artesunate | Tablet | 100 mg | |
| doxycycline | Tablet | 100mg | |
| mefloquine | Tablet | 250 mg (hydrochloride) | |
| primaquine | Tablet | 15 mg (as diphosphate) | |
| primaquine | Tablet | 7.5 mg (as diphosphate) | |
| quinine | Injection | 300 mg quinine hydrochloride/mL in 2-mL ampoule |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| abacavir | Suspension | 20 mg/ml x 240 ml | |
| abacavir | Tablet | 300 mg | |
| efavirenz (EFV or EFZ) | Tablet | 600 mg | |
| efavirenz (EFV or EFZ) | Tablet (scored) | 200 mg | |
| lamivudine (3TC) | Oral solution | 10mg/mL (100mL) | |
| lamivudine (3TC) | Oral solution | 10mg/mL (240mL) | |
| lamivudine (3TC) | Tablet | 150 mg | |
| lamivudine + nevirapine + stavudine | Tablet | 150 mg + 200 mg + 30 mg | |
| lamivudine + nevirapine + zidovudine | Tablet | 150 mg + 200 mg + 300 mg | |
| lamivudine + zidovudine | Tablet | 150 mg + 300 mg | |
| lopinavir + ritonavir (LPV/r) | Capsule | 133.3 mg + 33.3 mg | |
| lopinavir + ritonavir (LPV/r) | Oral liquid | 80 + 20 mg/ml | |
| nevirapine (NVP) | Suspension | 10mg/ml | |
| nevirapine (NVP) | Tablet | 200 mg | |
| stavudine (d4T) | Tablet | 30 mg | |
| tenofovir | Tablet | 300 mg | |
| zidovudine (ZDV or AZT) | Oral liquid | 10 mg/mL (100 mL) | |
| zidovudine (ZDV or AZT) | Oral liquid | 10 mg/mL (300 mL) | |
| zidovudine (ZDV or AZT) | Solid oral dosage form | 100 mg | |
| zidovudine (ZDV or AZT) | Solid oral dosage form | 300 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| benznidazole | Tablet | 100 mg | |
| benznidazole | Tablet | 50 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| acetylsalicylic acid | Tablet | 500 mg | |
| paracetamol | Tablet | 500 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| propranolol | Tablet | 40 mg (hydrochloride) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| azathioprine | Tablet | 50 mg | |
| ciclosporin | Capsule | 25 mg | |
| ciclosporin | Capsule | 50 mg | |
| methylprednisolone | Injection | 40 mg/ml |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| all trans retinoid acid (ATRA) | Capsule | 10 mg | |
| asparaginase | Powder for injection | 10 000 IU in vial | |
| bleomycin | Powder for injection | 15 mg (as sulfate) in vial | |
| capecitabine | Tablet | 150 mg | |
| capecitabine | Tablet | 500 mg | |
| chlorambucil | Tablet | 2 mg | |
| chlormethine | Powder for injection | 10 mg | |
| cisplatin | Powder for injection | 10 mg in vial | |
| cyclophosphamide | Powder for injection | 200 mg | |
| cyclophosphamide | Powder for injection | 500 mg in vial | |
| cytarabine | Powder for injection | 100 mg in vial | |
| dacarbazine | Powder for injection | 200 mg | |
| dactinomycin | Powder for injection | 500 mcg in vial | |
| docetaxel | Injection | 20 mg/ml | |
| doxorubicin | Powder for injection | 10 mg in vial | |
| doxorubicin | Powder for injection | 50 mg in vial | |
| etoposide | Injection | 20 mg/mL in 5-mL ampoule | |
| fluorouracil | Injection | 50 mg/ml in 5-ml ampoule | |
| mercaptopurine | Tablet | 50 mg | |
| methotrexate | Injection | L.P.F 25MG/ML X 2ML | |
| methotrexate | Tablet | 2.5 mg (as sodium salt) | |
| oxaliplatin | Injection | 100 mg/ 20 ml in 20 ml vial | |
| oxaliplatin | Injection | 50 mg/ 10 ml in 10 ml vial | |
| paclitaxel | Powder for injection | 6 mg/ml | |
| procarbazine | Capsule | 50 mg (as hydrochloride) | |
| thalidomide | Solid oral dosage form | 100 mg | |
| vinblastine | Powder for injection | 10 mg (sulfate) in vial | |
| vincristine | Injection | 1 mg/mL |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| calcium folinate | Injection | 10 mg/mL | |
| calcium folinate | Tablet | 15 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| anastrozole | Tablet | 1mg | |
| bicalutamide | Tablet | 150 mg | |
| bicalutamide | Tablet | 50 mg | |
| conjugated estrogens | Tablet | 1.25 mg | |
| dexamethasone | Injection | 4 mg (phosphate)/mL | |
| dexamethasone | Solid oral dosage form | 1.5 mg | |
| medroxyprogesterone acetate | Tablet | 100 mg | |
| prednisolone | Tablet | 30 mg | |
| prednisolone | Tablet | 5 mg | |
| tamoxifen | Tablet | 20 mg (as citrate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| hydroxycarbamide | Solid oral dosage form | 500 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| biperiden | Injection | 5 mg (lactate) in 1-ml ampoule | |
| biperiden | Tablet | 2 mg (hydrochloride) | |
| levodopa + carbidopa | Tablet | 100 mg/ 25 mg | |
| levodopa + carbidopa | Tablet | 200 mg/ 50 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| ferrous fumarate | Oral liquid | 6 mg/mL | |
| ferrous fumarate | Tablet | 200 mg | |
| folic acid | Tablet | 0.5mg | |
| hydroxocobalamin | Injection | 1 mg/mL | |
| hydroxycarbamide | Solid oral dosage form | 500 mg | |
| iron + dextran complex | Injection | 50 mg/mL |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| desmopressin | Nasal spray | 0.1 mg (acetate)/mL | |
| heparin sodium | Injection | 5000 IU/mL in 5-mL vial | |
| nadroparina | Injection | 9500 IU Anti-Xa/ml (0.3ml) | |
| phenprocoumon | Tablet | 3 mg | |
| phytomenadione | Injection | 10 mg/mL in 1-mL vial | |
| phytomenadione | Injection | 2 mg/ml | |
| phytomenadione | Tablet | 10 mg | |
| protamine sulfate | Injection | 10 mg/mL in 5-mL ampoule |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| polygeline | Injection | 3.5% in 500ml vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| albumin | Injection | 20% | |
| anti-D immunoglobulin (human) | Injection | 500 IU | |
| factor IX | N/A | N/A | |
| factor VIII | Solution for injection | 500 UI | |
| plasma protein fraction | Injection | 4% (100mL) Pasteurized |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| bisoprolol | Tablet | 1.25 mg | |
| bisoprolol | Tablet | 2.5 mg | |
| bisoprolol | Tablet | 5 mg | |
| isosorbide dinitrate | Tablet (prolonged release) | 20 mg | |
| isosorbide dinitrate | Tablet (sublingual) | 5 mg | |
| verapamil | Tablet | 40 mg (hydrochloride) | |
| verapamil | Tablet | 80 mg (hydrochloride) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amiodarone | Injection | 50 mg/mL in 3-mL ampoule (hydrochloride) | |
| amiodarone | Tablet (HCI) | 200 mg (hydrochloride) | |
| bisoprolol | Tablet | 1.25 mg | |
| bisoprolol | Tablet | 2.5 mg | |
| bisoprolol | Tablet | 5 mg | |
| digoxin | Injection | 250 micrograms/mL in 2-mL ampoule | |
| digoxin | Oral liquid | 50 micrograms/mL | |
| digoxin | Tablet | 250 mcg | |
| digoxin | Tablet | 62.5 micrograms | |
| isoprenaline | Injection | 1 mg/mL | |
| lidocaine | Injection | 1% (hydrochloride) | |
| procainamide | Injection | 100 mg (hydrochloride)/mL | |
| sotalol | Tablet | 80 mg | |
| verapamil | Injection | 2.5 mg (hydrochloride)/mL in 2-mL ampoule | |
| verapamil | Tablet (prolonged release) | 120 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amlodipine | Tablet | 10 mg | |
| amlodipine | Tablet | 5 mg | |
| bisoprolol | Tablet | 1.25 mg | |
| bisoprolol | Tablet | 2.5 mg | |
| bisoprolol | Tablet | 5 mg | |
| enalapril | Tablet | 20 mg | |
| enalapril | Tablet | 5 mg | |
| hydralazine | Solution for injection | 20 mg/ ml | |
| hydralazine | Tablet | 50 mg (hydrochloride) | |
| hydrochlorothiazide | Tablet (scored) | 25 mg | |
| losartan | Tablet | 50mg | |
| methyldopa | Tablet | 250 mg | |
| sodium nitroprusside | Injection | 10 mg/mL/5 mL |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| bisoprolol | Tablet | 1.25 mg | |
| bisoprolol | Tablet | 2.5 mg | |
| bisoprolol | Tablet | 5 mg | |
| digoxin | Injection | 250 micrograms/mL in 2-mL ampoule | |
| digoxin | Oral liquid | 50 micrograms/mL | |
| digoxin | Tablet | 250 mcg | |
| digoxin | Tablet | 62.5 micrograms | |
| dobutamine | Injection | 250 mg | |
| dopamine | Injection | 40 mg/mL (hydrochloride) in 5-mL vial | |
| enalapril | Tablet | 20 mg | |
| enalapril | Tablet | 5 mg | |
| furosemide | Injection | 10 mg/mL in 2-mL ampoule | |
| furosemide | Tablet | 40 mg | |
| hydrochlorothiazide | Tablet (scored) | 25 mg | |
| losartan | Tablet | 50mg | |
| spironolactone | Tablet | 25 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| acetylsalicylic acid | Tablet | 80 mg | |
| streptokinase | Powder for injection | 1.5 million IU in vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| simvastatin | Tablet | 20 mg | |
| simvastatin | Tablet | 40 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| miconazole | Cream | 2% (nitrate) | |
| miconazole | Vaginal cream | 2% (nitrate) | |
| salicyclic acid + benzoic acid | Cream | 5%/ 5% | |
| selenium sulfide | Detergent-based suspension | 2% |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| fusidic acid | Ointment | 2% | |
| gentian violet | Solution | 1% | |
| iodine-povidone | Ointment | 10% | |
| iodine-povidone | Solution | 10% | |
| mupirocin | Ointment | 2% (nasal ointment) | |
| potassium permanganate | Solution | 0.1% | |
| silver sulfadiazine | Cream | 1% |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| betamethasone | Cream | 0.1% (as valerate) | |
| calamine | Lotion | 15% | |
| clobetasol | Cream | 0.05% | |
| clobetasol | Lotion | 0.05% (propionate) | |
| hydrocortisone | Cream | 1% (acetate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| benzoyl peroxide | Gel | 5% | |
| coal tar | paste | 5% | |
| fluorouracil | Ointment | 5% | |
| podophyllum resin | Solution | 10% to 25% | |
| salicylic acid | Cream | 10%- 20% | |
| salicylic acid | Solution | 5%-10% | |
| urea | Cream | 10% | |
| urea | Cream | 5% |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| benzyl benzoate | Lotion | 25% | |
| permethrin | Cream | 5% | |
| permethrin | Lotion | 1% |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| clindamycin | Solution | 1% | |
| methoxsalen | Solution | 0.15% | |
| tretinoin | N/A | N/A |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| fluorescein | Injection | 50mg/mL (disodium) | |
| fluorescein | strips | N/A | |
| tropicamide | Solution (eye drops) | 0.5% |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| barium sulfate | Powder for enema | 400 g | |
| barium sulfate | Powder for oral suspension | 150 g | |
| ethyl esters of iodinated fatty acids of poppy oil | Injection | 480 mg/mL | |
| iohexol | Injection | 240 mg/mL | |
| iopamidol (iopromide) | Intravenous administration | Equiv 300 mg iodine in 20 mL-vial | |
| iopamidol (iopromide) | Intravenous administration | Equiv300 mg iodine in 50 mL vial | |
| ioxaglic acid | Injection | 320 mg/mL | |
| metrizoic acid | Solution | 100mg/L (bladder fluid) | |
| metrizoic acid | Solution | 350 mg/mL |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| chlorhexidine | mouth wash | 0.2% | |
| chlorhexidine | Solution | 0.5% alcohol solution (digluconate) | |
| hydrogen peroxide | Solution | 3% | |
| iodine-povidone | Solution | 10% |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| glutaraldehyde | Solution | 2% | |
| sodium hypochlorite | Solution | 0.25% |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| furosemide | Injection | 10 mg/mL in 2-mL ampoule | |
| furosemide | Tablet | 40 mg | |
| hydrochlorothiazide | Tablet (scored) | 25 mg | |
| mannitol | Injectable solution | 10% | |
| spironolactone | Tablet | 25 mg | |
| triamterene | Solid oral dosage form | 50 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| aluminum + magnesium hydroxide | Suspension | N/A | |
| aluminum + magnesium hydroxide | Tablet | 300mg/ 200mg | |
| cimetidine | Injection | 100 mg/mL | |
| omeprazole | Tablet | 20 mg | |
| omeprazole | Tablet | 40 mg | |
| ranitidine | Tablet | 150 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| dexamethasone | Tablet | 4 mg | |
| dimenhydrinate | Suppository | 10 mg | |
| dimenhydrinate | Suppository | 50 mg | |
| domperidone | Tablet | 10 mg | |
| metoclopramide | Injection | 5 mg (hydrochloride)/mL in 2-mL ampoule | |
| ondansetron | Tablet | 4 mg | |
| ondansetron | Tablet | 8 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| beclometasone | enema | 3 mg | |
| mesalazine | enema | 1G | |
| mesalazine | Tablet | 500 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| butyl scopolamine | Injection | 20 mg/ml | |
| butyl scopolamine | Tablet | 10mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| loperamide | Solid oral dosage form | 2mg | |
| oral rehydration salts | Powder for dilution | 1 L | |
| zinc sulfate | Solid oral dosage form | 20 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| glibenclamide | Tablet | 5 mg | |
| Insulin | Injection | (intermediate acting) 100U/mL in 10 mL | |
| Insulin | Injection | (long acting) 100U/mL in 10 mL | |
| Insulin | Injection | (short acting) 100U/mL in 10 mL | |
| metformin | Tablet | 500 mg | |
| tolbutamide | Tablet | 500 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| dexamethasone | Solid oral dosage form | 0.5 mg | |
| dexamethasone | Solid oral dosage form | 1.5 mg | |
| fludrocortisone | Tablet | 0.1 mg | |
| hydrocortisone | Injection | 100 mg (as sodium succinate) | |
| hydrocortisone | Tablet | 20 mg | |
| methylprednisolone | Powder for injection | 500 mg (succinate) in vial | |
| prednisolone | Injection | 25 mg/mL | |
| prednisolone | Tablet | 30 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| testosterone | Injection | 250mg/ mL in 1 mL |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| desogestrel | Tablet | 0.075 mg | |
| ethinylestradiol + levonorgestrel | Tablet | 3-phase 30microg + 50microg/ 40microg + 75microg/ 30microg + 125microg | |
| ethinylestradiol + levonorgestrel | Tablet | 30 mcg + 150 mcg | |
| ethinylestradiol + levonorgestrel | Tablet | 50 mcg/ 250 mcg | |
| levonorgestrel | Tablet | 1.5 mg | |
| levonorgestrel | Tablet | 30 micrograms | |
| levonorgestrel-releasing implant | N/A | Two-rod levonorgestrel-releasing implant, each rod containing 75 mg of levonorgestrel (150 mg total) | |
| medroxyprogesterone acetate | Depot injection | 150 mg/mL in 1-mL vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| copper-containing device | N/A | N/A |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| condoms | N/A | N/A |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| clomiphene citrate | Tablet | 50 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| Lynestrenol | Tablet | 5 mg | |
| norethisterone | Tablet | 5mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| carbimazole | Tablet | 5 mg | |
| levothyroxine | Tablet | 100 mcg (sodium salt) | |
| levothyroxine | Tablet | 25 mcg (sodium salt) | |
| levothyroxine | Tablet | 50 mcg (sodium salt) | |
| potassium iodide | Solution | 10% | |
| tiamazol | Tablet | 30 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| desmopressin | Nasal solution | 0.1 mg (acetate)/mL |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| triamcinolone | Injection | (acetonide) 10 mg/mL in 1 mL |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| tuberculin, purified protein derivative (PPD) | N/A | N/A |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| anti-hepatitis B immunoglobulin | Solution for injection | 150 IU | |
| antitetanus immunoglobulin (human) | Solution for injection | 250 IU | |
| polyvalent anti snake venom serum | Injection | 10ml |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| diphtheria and tetanus toxoid | Injection | pediatric | |
| diphtheria, tetanus toxoid | Injection | adult | |
| diphtheria, tetanus toxoid + pertussis vaccine | Injection | N/A | |
| MMR vaccine | Injection | measles, mumps and rubella live virus | |
| pentavalent vaccine | Injection | diphtheria-tetanu toxoid, whole cell pertussis, hepatitis B, H. influenzae b (Hib) | |
| poliomyelitis vaccine | Oral liquid | N/A | |
| yellow fever vaccine | N/A | N/A |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| hepatitis B vaccine | Injection | adult | |
| hepatitis B vaccine | Injection | pediatric | |
| human papilloma virus (HPV) vaccine | N/A | N/A | |
| rabies vaccine | N/A | N/A |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| baclofen | Tablet | 10 mg | |
| baclofen | Tablet | 25 mg | |
| neostigmine | Injection | 500 mcg (methylsulfate) in 1-mL ampoule | |
| pancuronium | Injection | 2 mg (bromuro)/mL | |
| pyridostigmine | Tablet | 60 mg (bromide) | |
| rocuronium bromide | Solution for injection | 50 mg/ 5 ml | |
| suxamethonium | Injection | 50 mg (chloride)/ml in 2-ml ampoule |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| aciclovir | Eye ointment | 3% | |
| gentamicin | Eye ointment | (sulfate) 0.5% | |
| gentamicin | Solution (eye drops) | 0.3% (sulfate) | |
| tetracycline | Eye ointment | 1% (hydrochloride) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| dexamethasone | Solution (eye drops) | 0.1% | |
| prednisolone | Eye ointment | 0.5% (5mg/g) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| phenylephrine | Solution (eye drops) | 1.25mg/ml (5ml) (hydrochloride) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| lidocaine | Solution (eye drops) | 4% |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| acetazolamide | Tablet | 250 mg | |
| dorzolamide | Solution (eye drops) | 2% | |
| dorzolamide + timolol | eye drops | 2%/ 0.5% | |
| latanoprost | Solution (eye drops) | 0.005% | |
| pilocarpine | Solution (eye drops) | 2% (hydrochloride) | |
| pilocarpine | Solution (eye drops) | 4% (hydrochloride) | |
| timolol | Solution (eye drops) | 0.5 % |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| atropine | Solution (eye drops) | 0.5% (sulfate) | |
| atropine | Solution (eye drops) | 1% (sulfate) | |
| homatropine | Solution (eye drops) | 2% | |
| phenylephrine | Solution (eye drops) | 10% | |
| phenylephrine | Solution (eye drops) | 15% | |
| phenylephrine | Solution (eye drops) | 5% |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| carbomer | Eye gel | 3 mg/mL (0.03%) | |
| diclofenac | Solution (eye drops) | 0.1% | |
| hypromellose | Solution (eye drops) | 0.3% |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| acetic acid | ear drops | 0.7% | |
| beclometasone | Nasal spray | 50 mcg | |
| lidocaine | drops | 0.5% (5 mL) | |
| miconazole | drops | 2% | |
| oxymethazoline | Nasal spray | 0.25 mg/ml | |
| oxymethazoline | Nasal spray | 0.5 mg/ml |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| ergometrine | Injection | 0.2 mg/mL (maleate) in 1-mL ampoule | |
| misoprostol | Tablet | 200 mcg | |
| oxytocin | Injection | 10 IU in 1-mL ampoule |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| nifedipine | Tablet | 20 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amino acids | Injection | 8% | |
| lipid emulsion | Emulsion | 10% |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| chlorpromazine | Injection | 25 mg (hydrochloride)/mL in 2-mL ampoule | |
| chlorpromazine | Tablet | 100 mg | |
| flufenazine | Tablet | 5 mg (hydrochloride) | |
| flufenazine decanoate | Solution for injection | 25 mg/ ml | |
| haloperidol | Injection | 100 mg/mL (decanoate) | |
| haloperidol | Injection | 5 mg/mL in 1-mL ampoule | |
| haloperidol | Oral liquid | 2 mg/mL | |
| haloperidol | Tablet | 2 mg | |
| haloperidol | Tablet | 5 mg | |
| pimozide | Tablet | 1 mg | |
| pimozide | Tablet | 4 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| citalopram | Tablet | 20 mg | |
| maprotiline | Tablet | 25 mg (hydrochloride) | |
| maprotiline | Tablet | 75 mg (hydrochloride) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| carbamazepine | Tablet (chewable) | 100 mg | |
| carbamazepine | Tablet (chewable) | 200 mg | |
| lithium carbonate | Tablet (controlled release) | 400 mg | |
| valproic acid (sodium valproate) | Tablet | 300 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| clorazepate | Capsule | 5 mg | |
| diazepam | Injection | 10 mg in 2-mL ampoule | |
| diazepam | Tablet (scored) | 10 mg | |
| diazepam | Tablet (scored) | 5 mg | |
| lorazepam | Tablet (scored) | 2.5 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| clomipramine | Solid oral dosage form | 10 mg | |
| clomipramine | Solid oral dosage form | 25 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| nicotine replacement therapy (NRT) | Chewing gum | 4 mg (as polacrilex) | |
| nicotine replacement therapy (NRT) | Transdermal patches | 14 mg/ 24 hr |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| beclometasone | Inhalation (aerosol) | 100 micrograms (dipropionate) per dose (as CFC free forms) | |
| ipratropium bromide | Inhalation (aerosol) | 20 micrograms/metered dose | |
| salbutamol | Inhalation (aerosol) | 100 mcg (as sulfate) per dose | |
| salbutamol | Injection | 1 mg/ mL - 5 mL | |
| salbutamol | Oral liquid | 2 mg/5 mL | |
| salbutamol | respirator solution for use in nebulizers | 5 mg (as sulfate)/mL | |
| theophylline | Tablet | 175 mg | |
| theophylline | Tablet | 350 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| codeine | Tablet | 10mg | |
| cough expectorant liquid | N/A | Mixtura Resolvens |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| caffeine citrate | Injection | 20 mg/ml (equivalent to 10 mg caffeine base/ml) | |
| caffeine citrate | Oral liquid | 20 mg/ml (equivalent to 10 mg caffeine base/ml) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| aluminum hydroxide | Tablet | 500 mg | |
| calcium acetate/ magnesium carbonate | Tablet | 435 mg/235 mg | |
| oral rehydration salts | Powder for dilution | 1 L | |
| potassium chloride | Oral solution | 75 mg/mL | |
| sodium polystrene sulphonate | Powder | 454 g |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| glucose | Parenteral formulation | 10% (100mL) | |
| glucose | Parenteral formulation | 10% (500 mL) | |
| glucose | Parenteral formulation | 40% (20mL) | |
| glucose | Parenteral formulation | 40% (50mL) | |
| glucose | Parenteral formulation | 5% (100 mL) | |
| glucose | Parenteral formulation | 5% (500 mL) | |
| glucose with sodium chloride | injection for intravenous administration | 2.5% glucose + 0.45% sodium chloride (500 mL) | |
| glucose with sodium chloride | injection for intravenous administration | 5% glucose + 0.9% sodium chloride (500 mL) | |
| glucose with sodium chloride | Solution for IV infusion injection | 3.75%/ 0.225% (500mL) | |
| potassium chloride | Injection | 7.46% | |
| sodium bicarbonate | Injection | 8.4% | |
| sodium bicarbonate | Injection | 8.4% (100mL) | |
| sodium bicarbonate | Solution for IV infusion | 1.4% (100mL) | |
| sodium chloride | Parenteral formulation | 0.9% (100 mL) | |
| sodium chloride | Parenteral formulation | 0.9% (1000mL) | |
| sodium chloride | Parenteral formulation | 0.9% (500 mL) | |
| sodium chloride | Parenteral formulation | 20% (30mL) | |
| sodium lactate co hartman full | injection for intravenous administration | 500 mL |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| water for injection | N/A | 10-ml ampoules | |
| water for injection | N/A | 30 mL | |
| water for injection | N/A | 5-mL ampoules |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| alfacalcidol | Tablet | 0.25 mcg | |
| ascorbic acid | Tablet | 50 mg | |
| calcium gluconate | Injection | 9.5mg/ml (10mL) | |
| cholecalciferol | Oral solution | 50000 IU/mL (100mL) | |
| pyridoxine | Tablet | 50 mg | |
| retinol | Capsule | 50 000 IU (as palmitate) | |
| retinol | Oral solution | (palmitate) 100.000 IU/ml (100ml) | |
| thiamine | Tablet | 50 mg (hydrochloride) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| abacavir | Tablet | 300 mg | |
| abacavir (ABC) | Oral liquid | 20mg/ml | |
| efavirenz (EFV or EFZ) | Tablet | 600 mg | |
| efavirenz (EFV or EFZ) | Tablet (scored) | 200 mg | |
| lamivudine (3TC) | Oral solution | 10mg/mL (100mL) | |
| lamivudine (3TC) | Oral solution | 10mg/mL (240mL) | |
| lamivudine (3TC) | Tablet | 150 mg | |
| lamivudine + nevirapine + stavudine | Tablet | 150 mg + 200 mg + 30 mg | |
| lamivudine + nevirapine + zidovudine | Tablet | 150 mg + 200 mg + 300 mg | |
| lamivudine + zidovudine | Tablet | 150 mg + 300 mg | |
| lopinavir + ritonavir (LPV/r) | Capsule | 133.3 mg + 33.3 mg | |
| lopinavir + ritonavir (LPV/r) | Oral liquid | 80 + 20 mg/ml | |
| nevirapine (NVP) | Suspension | 10mg/ml | |
| nevirapine (NVP) | Tablet | 200 mg | |
| stavudine (d4T) | Capsule | 30 mg | |
| tenofovir | Tablet | 300 mg | |
| zidovudine (ZDV or AZT) | Oral liquid | 10 mg/mL (100 mL) | |
| zidovudine (ZDV or AZT) | Oral liquid | 10 mg/mL (300 mL) | |
| zidovudine (ZDV or AZT) | Solid oral dosage form | 100 mg | |
| zidovudine (ZDV or AZT) | Solid oral dosage form | 300 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| anti-D immunoglobulin (human) | Injection | 500 IU | |
| azithromycin | Tablet | 250 mg | |
| bromocriptine mesylate | Tablet | 2.5 mg | |
| clarithromycin | Tablet | 500 mg | |
| diloxanide | Tablet | 500 mg (furoate) | |
| erythropoetin | Injection | 4,000 IU | |
| factor IX | N/A | N/A | |
| factor VIII | Solution for injection | 500 UI | |
| fluconazole | Tablet | 200 mg | |
| human normal immunoglobulin | Injection | 10% | |
| iron + dextran complex | N/A | 50 mg/ml | |
| losartan | Tablet | 50mg | |
| macrogol | Powder for solution | 4 g | |
| melphalan | Tablet | 2 mg | |
| mesalazine | Tablet | 500 mg | |
| methylphenidate | Tablet | 10 mg | |
| methylprednisolone | Injection | 500 mg (sodium succinate) | |
| mifepristone + misoprostol | Tablet | Mifepristone 200mg tab (1) and Misoprostol 200 mcg (4) combo pack | |
| nadroparina | Injection | 9500 IU Anti-Xa/ml (0.3ml) | |
| octreotide | Injection | 0.2 mg/ml (1ml) | |
| ondansetron | Tablet | 4 mg | |
| ondansetron | Tablet | 8 mg | |
| pralidoxime | Injection | 200 mg/mL (mesilate) | |
| sufentanil | Injection | 50 mcg/mL (5 mL) | |
| tamsulosin | Tablet | 0.4 mg | |
| thalidomide | Tablet | 100 mg | |
| vinblastine | Injection | 10 mg |